Delcath Insider Buying Surge Signals Confidence Ahead of Key Regulatory Milestones
Delcath Systems insider buying signals confidence in upcoming clinical or regulatory milestones, but investors must weigh high risk against potential growth in liver‑cancer therapy.
4 minutes to read